Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Vaccine. 2023 Mar 17;41(12):1916-1924. doi: 10.1016/j.vaccine.2023.01.042. Epub 2023 Jan 23.
INTRODUCTION: We studied characteristics of COVID-19 vaccination uptake among people who inject drugs (PWID). METHODS: Participants aged ≥18 years who injected drugs ≤1 month ago were recruited into a community-based cohort from October 2020 to September 2021 in San Diego, California Poisson regression identified correlates of having had ≥1 COVID-19 vaccine dose based on semi-annual follow-up interviews through March 15, 2022. RESULTS: Of 360 participants, 74.7% were male, mean age was 42 years; 63.1% were Hispanic/Mexican/Latinx. More than one-third had ≥1 co-morbidity. HIV and HCV seroprevalence were 4.2% and 50.6% respectively; 41.1% lacked health insurance. Only 37.8% reported having ≥1 COVID-19 vaccine dose. None received ≥3 doses. However, of those vaccinated, 37.5% were previously unwilling/unsure about COVID-19 vaccines. Believing COVID-19 vaccines include tracking devices (adjusted incidence rate ratio [aIRR]: 0.62; 95% CI: 0.42,0.92) and lacking health insurance (aIRR: 0.60; 95% CI: 0.40,0.91) were associated with approximately 40% lower COVID-19 vaccination rates). Ever receiving influenza vaccines (aIRR: 2.16; 95%CI: 1.46, 3.20) and testing HIV-seropositive (aIRR: 2.51; 95% CI: 1.03, 6.10) or SARS-CoV-2 RNA-positive (aIRR: 1.82; 95% CI: 1.05, 3.16) independently predicted higher COVID-19 vaccination rates. Older age, knowing more vaccinated people, and recent incarceration were also independently associated with higher COVID-19 vaccination rates. CONCLUSIONS: One year after COVID-19 vaccines became available to U.S. adults, only one third of PWID had received ≥1 COVID-19 vaccine dose. Multi-faceted approaches that dispel disinformation, integrate public health and social services and increase access to free, community-based COVID-19 vaccines are urgently needed.
引言:我们研究了新冠病毒疫苗在注射毒品者(PWID)中的接种特点。 方法:2020 年 10 月至 2021 年 9 月,我们从加利福尼亚州圣地亚哥的一个社区中招募了年龄≥18 岁且在过去 1 个月内≤1 次注射毒品的参与者。我们采用泊松回归分析,通过截至 2022 年 3 月 15 日的每半年一次的随访访谈,根据半年度随访调查,确定了≥1 剂新冠病毒疫苗接种的相关性。 结果:在 360 名参与者中,74.7%为男性,平均年龄为 42 岁;63.1%为西班牙裔/墨西哥裔/拉丁裔。超过三分之一的人患有≥1 种合并症。HIV 和 HCV 的血清阳性率分别为 4.2%和 50.6%;41.1%没有医疗保险。仅有 37.8%的人报告至少接种了 1 剂新冠病毒疫苗。没有 1 人接种了≥3 剂。然而,在接种疫苗的人群中,37.5%的人之前对新冠病毒疫苗持不愿意/不确定的态度。认为新冠病毒疫苗中包含跟踪装置(调整发病率比[aIRR]:0.62;95%CI:0.42,0.92)和缺乏医疗保险(aIRR:0.60;95%CI:0.40,0.91)与新冠病毒疫苗接种率降低约 40%有关。曾接种过流感疫苗(aIRR:2.16;95%CI:1.46,3.20)和 HIV 血清阳性(aIRR:2.51;95%CI:1.03,6.10)或 SARS-CoV-2 RNA 阳性(aIRR:1.82;95%CI:1.05,3.16)与较高的新冠病毒疫苗接种率有关。年龄较大、认识更多接种疫苗的人以及最近入狱与较高的新冠病毒疫苗接种率也有关。 结论:在美国成年人可接种新冠病毒疫苗一年后,仅有三分之一的 PWID 接种了≥1 剂新冠病毒疫苗。迫切需要采取多方面的方法来消除错误信息,整合公共卫生和社会服务,并增加免费的、社区为基础的新冠病毒疫苗接种机会。
Vaccine. 2023-3-17
Front Public Health. 2022
Harm Reduct J. 2022-6-3
BMC Health Serv Res. 2024-10-19
Health Aff (Millwood). 2024-6
J Acquir Immune Defic Syndr. 2024-4-1